Table 14Response rates in the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)224

InterventionAll PatientsModerate-Severe Baseline Pain (WOMAC Pain Score 301–400 mm)Mild Baseline Pain (WOMAC Pain Score 125–300)
Placebo60.1%54.3%61.7%
Celecoxib70.1% (p=0.008 vs. placebo)69.4% (p=0.06 vs. placebo)70.3% (p=0.04 vs. placebo)
Glucosamine64.0% (p=0.30 vs. placebo)65.7% (p=0.17 vs. placebo)63.6% (p=0.67 vs. placebo)
Chondroitin65.4% (p=0.17 vs. placebo)61.4% (p=0.39 vs. placebo)66.5% (p=0.27 vs. placebo)
Glucosamine + chondroitin66.6% (p=0.09 vs. placebo)79.2% (p=0.002 vs. placebo)62.9% (p=0.80 vs. placebo)

GAIT = Glucosamine/chondroitin Arthritis Intervention Trial; WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index

From: Results

Cover of Analgesics for Osteoarthritis
Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review [Internet].
Comparative Effectiveness Reviews, No. 38.
Chou R, McDonagh MS, Nakamoto E, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.